High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

(2014) Oscar Arrieta et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma

(2013) Daniel E. Schwed Lustgarten et al.   Journal of Thoracic Oncology

Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2 Useful for Noninvasive Monitoring of Breast Tumor Response to Antiangiogenic Linifanib Therapy but not Anti-Integrin αvβ3 RGD2 Therapy

(2013) Shundong Ji et al.   Theranostics

First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

(2012) Ó Arrieta et al.   BRITISH JOURNAL OF CANCER

Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations

(2012) Carmine Pinto et al.   CANCER TREATMENT REVIEWS

Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma

(2012) Steven C.H. Kao et al.   Clinical Lung Cancer

Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer

(2012) Eric S. Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?

(2011) S. Sharif et al.   Interactive Cardiovascular and Thoracic Surgery

Combination Radiofrequency Ablation and Intravenous Radiolabeled Liposomal Doxorubicin: Imaging and Quantification of Increased Drug Delivery to Tumors

(2010) Hayden W. Head et al.   RADIOLOGY

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

(2008) J B Sørensen et al.   BRITISH JOURNAL OF CANCER

Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: A review of practice in British Columbia

(2008) Christopher W. Lee et al.   LUNG CANCER